Treatment with Sevelamer Decreases Bicarbonate Levels in Hemodialysis Patients

Publisher： Karger

E-ISSN： 2235-3186|92|2|499-500

ISSN： 1660-8151

Source： Nephron, Vol.92, Iss.2, 2002-09, pp. : 499-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis

By  

American Journal of Nephrology, Vol. 44, Iss. 5, 2016-10 ,pp. : 404-410

Karger

Access to resources Recommend Favorite

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients on Sevelamer Hydrochloride: Which Dialysate Calcium Concentration to Use?

By  

Blood Purification, Vol. 27, Iss. 2, 2009-01 ,pp. : 182-186

Karger

Access to resources Recommend Favorite

Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients

By  

Blood Purification, Vol. 24, Iss. 4, 2006-08 ,pp. : 379-386

Karger

Access to resources Recommend Favorite

Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency

By  

Nephron, Vol. 131, Iss. 3, 2015-0 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Plasma Adrenomedullin Levels in Patients on Hemodialysis

By  

Nephron, Vol. 89, Iss. 1, 2001-08 ,pp. : 20-25

Karger

Access to resources Recommend Favorite